APA (7th ed.) Citation

N, N., MK, Y., AV, S., H, K., S, W., J, P., & G, B. (2025). SARS-CoV-2 Vaccine-Induced Seroconversion and Immune Correlates in Patients with Hematological Malignancies. A Real World Study. Oncology research, 33(10), 2923. https://doi.org/10.32604/or.2025.067561

Chicago Style (17th ed.) Citation

N, Nass, Yaakoub MK, Simion AV, Kroll H, Westphal S, Pannier J, and Behre G. "SARS-CoV-2 Vaccine-Induced Seroconversion and Immune Correlates in Patients with Hematological Malignancies. A Real World Study." Oncology Research 33, no. 10 (2025): 2923. https://doi.org/10.32604/or.2025.067561.

MLA (9th ed.) Citation

N, Nass, et al. "SARS-CoV-2 Vaccine-Induced Seroconversion and Immune Correlates in Patients with Hematological Malignancies. A Real World Study." Oncology Research, vol. 33, no. 10, 2025, p. 2923, https://doi.org/10.32604/or.2025.067561.